Infiltration rate of Butamirate Citrate in therapeutic market (Q3, 2019)


MedAnalytics measures Butamirate Citrate market penetration in different clinical practices. The report is often a source of untapped market potential that might exist in own brand marketing.The market penetration of Butamirate Citrate varied in different clinical practices. last one year period, market penetrations was observed 13% in oncologists, 11% in pediatricians, 11% in general physicians, 10% in internal medicine specialists, 9% in endocrinologists, 9% in diabetologists, 8% in pediatric surgeons, 8% in neurosurgeons, 8% in gastroenterologists, 8% in orthopaedic surgeons, 8% in ent specialists, 7% in nephrologists, 7% in dermatologists, 7% in gynecologists & obstetricians, 7% in cardiologists, 6% in plastic surgeons, 6% in colorectal surgeons, 6% in ophthalmologists, 6% in rheumatology specialists, 6% in respiratory medicine specialists, 6% in general & laparoscopic surgeons, 6% in physical medicine specialists, 5% in hepatologists, 5% in urologists, 5% in psychiatrists, 5% in neurologists, 5% in cardio-vascular surgeons, 5% in critical care medicine specialists, 5% in anesthesia & icu specialists, 4% in infertility specialists, 4% in orofacial & maxillary surgeons, 4% in hematologists, 4% in cancer surgeons, 4% in dentists and 3% in hepatobiliary surgeons.For example, market penetration rate of a generic found 10% in dermatology practice. It means, 10% dermatology practitioners are potential to prescribe this generic. This kind of report is often a source for discovering an untapped market potential that may exist around in marketing own brand.

You might be interested to